Estradiol / Norethindrone Acetate
Product Images NDC 54868-4677

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Estradiol / Norethindrone Acetate (NDC 54868-4677). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (1.0 mg / 0.5 mg Carton)

Principal Display Panel (1.0 mg / 0.5 mg Carton)
This appears to be a product label for a medication called "Estradiol Norethin," with a strength of 1 mg/0.5 mg. The manufacturer listed is Physicians Total Care, with a lot number of 0680 and expiration date of 81/60 (possibly June 2081). The NBC code may be a product code.*
FDA Label Image

Chemical Structure (Ena 01)

FDA Label Image

Chemical Structure (Ena 02)

FDA Label Image

Figure 1a (Ena 03)

Figure 1a (Ena 03)
This appears to be a graph showing the concentration of 2-Estradiol and o-Estrone over time in units of pg/mi. Without further context, it's difficult to determine the source of the data or its significance.*
FDA Label Image

Figure 1b (Ena 04)

FDA Label Image

Figure 2 (Ena 05)

Figure 2 (Ena 05)
This appears to be a table displaying the number of hot flushes per week for different treatments. The treatments listed are "Placebo", "1 mg Estradiol", and "Estradiol/Norethindrone Acetate Tablets 1.0 mg/0.5 mg". It is unclear what condition or study is being referenced aside from the severity of hot flushes being "moderate-severe".*
FDA Label Image

Figure 3 (Ena 06)

Figure 3 (Ena 06)
The text describes the number of moderate to severe hot flushes in two groups of participants, one group taking Estradiol/Norethindrone Acetate Tablets and another group taking a placebo. The sample sizes are 154 and 199 respectively.*
FDA Label Image

Figure 4 (Ena 07)

FDA Label Image

Figure 5 (Ena 08)

FDA Label Image

Figure 6 (Ena 09)

Figure 6 (Ena 09)
This is a comparison of the effects of Estradiol and Norethindrone Acetate Tablets in two different groups (U and Us) with different dosages, 1.0 mp/0.5 mg and 1.0 ma/0.5 mg respectively. The change in percentage is being tracked over a lunar month's duration (28 day cycles). No further information can be obtained from this text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.